Priority Date: 07.03.12 (IN 2012MUM612)

NOVEL COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND RELATED DISEASES

  • Application ID: EP12795080
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 201 - 500 employees
Company dna zacco
operating since 2001
Headquarter in Copenhagen and 15 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 193 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 07.03.2012 - Priority Date (IN 2012MUM612)
  • 12.09.2013 - Publication A1 (WO2013132509)
  • 14.01.2015 - Publication A1 (EP2822940)
  • 15.02.2017 - Publication B1 (EP2822940)